Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

Authors: Juan P. Frías, Melanie J. Davies, Julio Rosenstock, Federico C. Pérez Manghi, Laura Fernández Landó et al.

Year: 2021

SemaglutideAgonistGlucagon-like peptide 1 receptorType 2 diabetesMedicine